Kaya Herbs ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 9.5% 14.6% 8.7% 8.8%  
Credit score (0-100)  0 28 15 30 28  
Credit rating  N/A BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -25.3 -130 -64.2 -387  
EBITDA  0.0 -25.3 -136 -109 -595  
EBIT  0.0 -30.3 -173 -147 -851  
Pre-tax profit (PTP)  0.0 -30.5 -184.8 -157.1 -977.4  
Net earnings  0.0 -24.0 -148.1 -123.9 -705.4  
Pre-tax profit without non-rec. items  0.0 -30.5 -185 -157 -977  

 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 157 180 148 3,936  
Shareholders equity total  0.0 26.0 167 193 538  
Interest-bearing liabilities  0.0 169 0.0 159 1,346  
Balance sheet total (assets)  0.0 172 301 613 6,589  

Net Debt  0.0 169 -0.3 109 1,346  
 
See the entire balance sheet

Volume 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -25.3 -130 -64.2 -387  
Gross profit growth  0.0% 0.0% -413.5% 50.5% -502.8%  
Employees  0 0 0 1 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% 200.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 172 301 613 6,589  
Balance sheet change%  0.0% 0.0% 75.4% 103.4% 974.8%  
Added value  0.0 -25.3 -136.0 -110.1 -595.1  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 152 -15 264 4,396  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 119.8% 133.6% 229.7% 219.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -17.6% -73.3% -32.3% -23.6%  
ROI %  0.0% -14.9% -93.8% -56.9% -29.7%  
ROE %  0.0% -92.1% -153.4% -68.8% -193.1%  

Solidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  0.0% 15.1% 55.4% 31.5% 8.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -667.5% 0.2% -99.8% -226.1%  
Gearing %  0.0% 648.4% 0.0% 82.3% 250.3%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.2% 13.5% 12.1% 16.8%  

Liquidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.0 0.1 0.8 0.3 0.5  
Current Ratio  0.0 0.1 0.8 0.3 0.5  
Cash and cash equivalent  0.0 0.0 0.3 50.1 0.0  

Capital use efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 -123.6 -28.6 -289.5 -1,204.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -110 -198  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -109 -198  
EBIT / employee  0 0 0 -147 -284  
Net earnings / employee  0 0 0 -124 -235